… reported a major advance in cancer treatment after using artificial … is often limited because cancer cells evolve and evade … , his team developed a patented, AI-driven diagnostic technology that … open new pathways for targeted gene, viral and mRNA-based …

… -expression strategies—directly fusing antibody genes to the GvpC C-terminus … gene fragment that had been optimized for codons (designed based on patent … concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation …

… authorities. The newly granted patent is separate from earlier intellectual … to carry three therapeutic genes -- PH-20, sPD1 … killer cells. Together, the genes are designed to improve … to stay competitive in global cancer gene-therapy development.” KLS-3021 …

… ), and the timeline of patent applications or key research publications … to activate pro-oncogenic genes such as Cyclin D1 … Autophagy inhibition in BRAF-driven cancers. Cancers. 2021;13(14):3498. … in non-small cell lung cancer. Cancers. 2020;12(1):193. …

Sperm Bank Sold Man’s Cancer-Linked Genes Across Europe more... Toronto: Inside … Lloyd & Mousilli Expands Patent Litigation and IP Services Across … Technologies and ExeQuantum Announce Joint Patent for SiFA, a Breakthrough Crypto …

… development of cell and gene therapies. The patents cover a novel chimeric … cell and gene therapies — previously focused mainly on blood cancers — into solid … two patents, GC Cell aims to strengthen its cell and gene therapy …

… of chronic diseases such as cancer, diabetes, cardiovascular, and neurological … D, generic peptide launches post-patent expiry, strategic CDMO capacity expansions … production advancements powering next-generation gene therapies and precision medicine. ➡️  …

… , the other is its cancer therapy Sacituzumab Tirumotecan. Both … Teplizumab, and Regeneron’s gene therapy DB-OTO for congenital … breast, endometrial, and lung cancers. The funding agreement will help … drug Keytruda closes in on patent expiry, raising the risk …

… Decoction (MTD) was developed and patented in China.3 Studies have … used to calculate the relative gene expression. The primer sequences (synthetic … MTD EC-Related Target Genes With “esophagus cancer” as the keyword, 22 …

… structural rearrangements. These cancers also exhibited elevated levels … fragments that carry cancer‑promoting genes and are strongly … by the National Cancer Institute and Cancer Research UK. … declares U.S. provisional patent applications serial numbers 63…